Martin Schlumberger

75.0k total citations · 15 hit papers
387 papers, 50.2k citations indexed

About

Martin Schlumberger is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Martin Schlumberger has authored 387 papers receiving a total of 50.2k indexed citations (citations by other indexed papers that have themselves been cited), including 305 papers in Endocrinology, Diabetes and Metabolism, 109 papers in Surgery and 71 papers in Oncology. Recurrent topics in Martin Schlumberger's work include Thyroid Cancer Diagnosis and Treatment (273 papers), Thyroid and Parathyroid Surgery (60 papers) and Thyroid Disorders and Treatments (55 papers). Martin Schlumberger is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (273 papers), Thyroid and Parathyroid Surgery (60 papers) and Thyroid Disorders and Treatments (55 papers). Martin Schlumberger collaborates with scholars based in France, Italy and United States. Martin Schlumberger's co-authors include Furio Pacini, Steven I. Sherman, Bryan R. Haugen, R. Michael Tuttle, Susan J. Mandel, David L. Steward, Sophie Leboulleux, Éric Baudin, Bernard Caillou and Rossella Elisei and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Martin Schlumberger

378 papers receiving 49.0k citations

Hit Papers

2015 American Thyroi... 1985 2026 1998 2012 2015 2009 2006 2015 2015 2.5k 5.0k 7.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Schlumberger France 93 39.8k 19.9k 9.0k 8.0k 7.1k 387 50.2k
Furio Pacini Italy 74 30.5k 0.8× 15.4k 0.8× 4.7k 0.5× 5.1k 0.6× 5.0k 0.7× 258 35.2k
Yuri E. Nikiforov United States 82 26.3k 0.7× 9.9k 0.5× 6.9k 0.8× 2.6k 0.3× 3.2k 0.4× 250 32.8k
R. Michael Tuttle United States 76 30.7k 0.8× 17.0k 0.9× 4.0k 0.4× 3.4k 0.4× 5.3k 0.7× 326 34.1k
Rossella Elisei Italy 72 18.4k 0.5× 6.2k 0.3× 5.5k 0.6× 3.6k 0.4× 2.2k 0.3× 370 23.3k
Bryan R. Haugen United States 53 23.6k 0.6× 12.4k 0.6× 3.4k 0.4× 2.7k 0.3× 3.8k 0.5× 159 27.7k
Electron Kebebew United States 69 9.8k 0.2× 7.7k 0.4× 4.3k 0.5× 3.3k 0.4× 862 0.1× 378 19.1k
Douglas B. Evans United States 96 5.8k 0.1× 13.0k 0.7× 23.1k 2.6× 10.8k 1.3× 1.3k 0.2× 500 36.7k
Susan J. Mandel United States 50 24.6k 0.6× 13.0k 0.7× 2.3k 0.3× 2.8k 0.3× 3.7k 0.5× 99 28.0k
Ernest L. Mazzaferri United States 59 18.2k 0.5× 12.0k 0.6× 2.0k 0.2× 2.4k 0.3× 2.9k 0.4× 303 23.1k
Herbert Chen United States 68 7.8k 0.2× 7.8k 0.4× 4.2k 0.5× 3.5k 0.4× 622 0.1× 570 20.2k

Countries citing papers authored by Martin Schlumberger

Since Specialization
Citations

This map shows the geographic impact of Martin Schlumberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schlumberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schlumberger more than expected).

Fields of papers citing papers by Martin Schlumberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Schlumberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schlumberger. The network helps show where Martin Schlumberger may publish in the future.

Co-authorship network of co-authors of Martin Schlumberger

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Schlumberger. A scholar is included among the top collaborators of Martin Schlumberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Schlumberger. Martin Schlumberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porcelli, Tommaso, Cristina Luongo, Anna Maria Cerbone, et al.. (2025). Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?. European Thyroid Journal. 14(1). 1 indexed citations
2.
Brose, Marcia S., Jaume Capdevila, Rossella Elisei, et al.. (2024). Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocrine Related Cancer. 31(8). 4 indexed citations
3.
Leboulleux, Sophie, Corinne Dupuy, Ludovic Lacroix, et al.. (2019). Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment. Thyroid. 29(5). 735–742. 36 indexed citations
5.
Berdelou, A., Isabelle Borget, Yann Godbert, et al.. (2017). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. Thyroid. 28(1). 72–78. 102 indexed citations
6.
Haugen, Bryan R., Erik K. Alexander, Keith C. Bible, et al.. (2015). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 26(1). 1–133. 9985 indexed citations breakdown →
7.
Schlumberger, Martin, Barbara Jarząb, Maria E. Cabanillas, et al.. (2015). A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clinical Cancer Research. 22(1). 44–53. 184 indexed citations
8.
Elisei, Rossella, Martin Schlumberger, Stefan Müller, et al.. (2013). Cabozantinib in Progressive Medullary Thyroid Cancer. Journal of Clinical Oncology. 31(29). 3639–3646. 850 indexed citations breakdown →
9.
Wells, Samuel A., Bruce G. Robinson, Robert F. Gagel, et al.. (2011). Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial. Journal of Clinical Oncology. 30(2). 134–141. 1082 indexed citations breakdown →
10.
Broutin, Sophie, Nabahet Ameur, Ludovic Lacroix, et al.. (2011). Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models. Clinical Cancer Research. 17(7). 2044–2054. 30 indexed citations
11.
Wells, Samuel A., Jessica E. Gosnell, Robert F. Gagel, et al.. (2010). Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer. Journal of Clinical Oncology. 28(5). 767–772. 380 indexed citations
12.
Schlumberger, Martin, Rossella Elisei, Lars Bastholt, et al.. (2009). Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer. Journal of Clinical Oncology. 27(23). 3794–3801. 257 indexed citations
13.
Haddy, Nadia, Catherine Paoletti, Marie‐Gabrielle Dondon, et al.. (2009). Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy. Radiotherapy and Oncology. 93(2). 377–382. 14 indexed citations
14.
Cooper, David S., Gerard M. Doherty, Bryan R. Haugen, et al.. (2009). Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 19(11). 1167–1214. 5125 indexed citations breakdown →
15.
Bonnet, S., Dana M. Hartl, Sophie Leboulleux, et al.. (2008). Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment. The Journal of Clinical Endocrinology & Metabolism. 94(4). 1162–1167. 209 indexed citations
16.
Baudin, Éric, Anne Bachelot, Michel Ducreux, & Martin Schlumberger. (2001). Progrès récents dans la prise en charge des tumeurs endocrines. 3(4). 18–24. 2 indexed citations
17.
Baudin, Éric, Michel Ducreux, Jean‐Christophe Sabourin, et al.. (1999). Les tumeurs neuro-endocrines gastro-entéropancréatiques. 1(2). 165–174. 1 indexed citations
18.
Aplogan, Aristide, et al.. (1998). Une épidémie de méningite à méningocoque dans la région des Savanes au Togo en 1997 : investigation et stratégies de contrôle. Cahiers d'études et de recherches francophones / Santé. 7(6). 384–390. 3 indexed citations
19.
Schlumberger, Martin, Florent de Vathaire, J P Travagli, et al.. (1996). Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.. PubMed. 37(4). 598–605. 353 indexed citations
20.
Rougier, P, J Navarro, Martin Schlumberger, et al.. (1984). Néoplasies endocriniennes multiples type 2b. Aspects cliniques, diagnostiques et thérapeutiques.. Bulletin du Cancer. 71(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026